Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CNTA is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026
- Institutional holders
- 0
- −159 vs. Q1 2026
- Shares held
- 0
- −145.1M (−100.0%) vs. Q1 2026
- Total value
- $0
- −$5.76B (−100.0%) vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 159
- 0 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 0 | $0 | 0.00% | −19,963,157−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −11,430,455−100.0% | Sold out |
| Index Venture Life Associates VI Ltd | 0 | $0 | 0.00% | −9,961,789−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −8,925,010−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −8,170,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −6,852,047−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −6,000,000−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −5,258,903−100.0% | Sold out |
| Capital World Investors | 0 | $0 | 0.00% | −4,832,548−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −4,809,000−100.0% | Sold out |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −4,286,480−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −4,268,353−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −3,574,048−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −3,158,041−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −2,125,000−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −2,054,175−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,049,439−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −1,986,768−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,932,406−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −1,854,488−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −1,560,991−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −1,400,000−100.0% | Sold out |
| Foresite Capital Management VI LLC | 0 | $0 | 0.00% | −1,364,019−100.0% | Sold out |
| General Atlantic LLC | 0 | $0 | 0.00% | −1,354,830−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,144,560−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −1,053,464−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,050,000−100.0% | Sold out |
| Alpine Associates Management Inc. | 0 | $0 | 0.00% | −865,500−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −859,105−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −852,828−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −750,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −722,121−100.0% | Sold out |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0 | $0 | 0.00% | −702,254−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −687,427−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −684,482−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −670,751−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −668,142−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −654,850−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −648,326−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −643,808−100.0% | Sold out |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −635,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −628,049−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −625,420−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −598,197−100.0% | Sold out |
| 5AM Venture Management, LLC | 0 | $0 | 0.00% | −580,945−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −528,224−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −510,407−100.0% | Sold out |
| Spruce Street Capital LP | 0 | $0 | 0.00% | −489,849−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −466,345−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −390,951−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −359,939−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −351,828−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −477,597−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −325,001−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −320,430−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −307,355−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −278,064−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −274,116−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −254,803−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −242,044−100.0% | Sold out |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −236,785−100.0% | Sold out |
| Eagle Health Investments LP | 0 | $0 | 0.00% | −214,291−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −206,847−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −189,961−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −185,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −171,933−100.0% | Sold out |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −170,016−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −168,177−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −168,170−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −160,942−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −158,509−100.0% | Sold out |
| Burkehill Global Management, LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −137,741−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −116,992−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −111,956−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −109,327−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −110,207−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −107,778−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −98,028−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −96,367−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −93,685−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −74,276−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −71,513−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −67,775−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −96,910−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −59,844−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −50,606−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −41,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,968−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −39,656−100.0% | Sold out |
| Knott David M Jr | 0 | $0 | 0.00% | −39,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −38,812−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −38,566−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −36,254−100.0% | Sold out |
| Buckland Partners Management Co LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −29,670−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −25,350−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −24,174−100.0% | Sold out |